OTCMKTS:SHTDY Sinopharm Group (SHTDY) Stock Price, News & Analysis $13.31 +0.02 (+0.15%) (As of 07/3/2024 ET) Add Compare Share Share Today's Range$13.28▼$13.3150-Day Range$12.54▼$14.4952-Week Range$11.36▼$16.31Volume3,968 shsAverage Volume12,219 shsMarket CapitalizationN/AP/E Ratio2.67Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartDividendFinancialsHeadlinesShort InterestStock AnalysisChartDividendFinancialsHeadlinesShort Interest Get Sinopharm Group alerts: Email Address Ad Behind the MarketsMassive July 4th Discount InsideTo celebrate this Independence Day, we've arranged a special deal for you... We've partnered with Behind the Markets to make sure YOU get access to an exclusive 90% off sale not being offered to the public.Claim your exclusive offer here>>> About Sinopharm Group Stock (OTCMKTS:SHTDY)Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.Read More SHTDY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHTDY Stock News HeadlinesMay 14, 2024 | finance.yahoo.comSinopharm Group Leads Three Premier Dividend Stocks In Hong KongApril 30, 2024 | seekingalpha.comKaryopharm Therapeutics: Spiraling Despite Upcoming CatalystsJuly 5, 2024 | Colonial Metals (Ad)Silver Expected for Extreme Price ActionOur newest Silver Investing Guide reveals how savvy investors are capitalizing on silver's continued rise – PLUS a little-known loophole that allows investors to move a portion of their savings into silver, tax-free and penalty-free.April 29, 2024 | msn.comChina is gunning for the chief scientist of its COVID vaccine project, accusing him of 'serious discipline and law violations'April 13, 2024 | morningstar.comSinopharm Group Co LtdApril 8, 2024 | msn.comStudy: Pfizer vaccine showed strongest immune response in MoroccoMarch 27, 2024 | markets.businessinsider.comBuy Rating for Sinopharm Group Co. Amidst Market Consolidation and Efficiency GainsMarch 15, 2024 | tmcnet.comXinhua Silk Road: Electric tricycles made in E. China's Rizhao popular abroadJuly 5, 2024 | Colonial Metals (Ad)Silver Expected for Extreme Price ActionOur newest Silver Investing Guide reveals how savvy investors are capitalizing on silver's continued rise – PLUS a little-known loophole that allows investors to move a portion of their savings into silver, tax-free and penalty-free.February 25, 2024 | msn.comSinopharm Group Co. - Depositary Receipt () (SHTDY) Price Target Increased by 11.16% to 15.28February 22, 2024 | msn.comHong Kong Stocks: Sinopharm to Buyout China-TCM for HK$23.2BFebruary 21, 2024 | uk.finance.yahoo.comPharma Wholesale and Distribution market is projected to grow at a CAGR of 8.7% by 2034: VisiongainFebruary 19, 2024 | thestreet.comSinopharm Group Co Ltd ADRNovember 7, 2023 | morningstar.comSinopharm Group Co Ltd ADR SHTDYSeptember 5, 2023 | finance.yahoo.comHong Kong stocks slide amid China property default risk while Sinopharm slides on index debut, L'Occitane crashesMay 18, 2023 | msn.comWHO recommends updating COVID shots to add XBB.1 variantsMarch 30, 2023 | marketwatch.comChlorpheniramine Maleate Market Outlook and Forecast till 2031March 29, 2023 | morningstar.comSinopharm’s Earnings Slightly Better Than ExpectedMarch 29, 2023 | marketwatch.com2023-2029 Gold(III) Bromide (AuBr3) Market Size and Industrial Overview with Region Footprint | Latest Report by Absolute ReportsMarch 28, 2023 | marketwatch.com7-Aminocephalosporanic Acid (7-ACA) Market Outlook By 2031March 27, 2023 | marketwatch.comSpecialty Pharmacy Services Market Outlook By 2031March 24, 2023 | marketwatch.comGosling Plague Vaccine Market Top Players By 2031March 23, 2023 | marketwatch.comNew Report Predicts Significant Growth in Polysorbate 40 Market from 2023 to 2030March 21, 2023 | marketwatch.comGlobal Cobamamide Drugs Market: Future Extrapolations and Emerging Updates for 2023-2027March 21, 2023 | marketwatch.comChain Drugstores Market Top Players and Forecast till 2029March 13, 2023 | marketwatch.comAmmonium Phosphomolybdate Market Size, Share and Forecast 2028 with Top Countries DataMarch 13, 2023 | marketwatch.comChain Drugstores Market Size 2023 Will Grow Rapidly Another Level In The Forthcoming Year 2029See More Headlines Receive SHTDY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 8/28 Dividend6/18/2024Today7/04/2024Dividend Payable8/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Distribution Sub-IndustryN/A Current SymbolOTCMKTS:SHTDY CUSIPN/A CIK1556605 Webwww.sinopharmgroup.com.cn Phone86-21-2305-2666FaxN/AEmployees115,959Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio2.67 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Qingming Yu (Age 60)Executive Chairman of the Board Comp: $913.1kMr. Yong Liu (Age 55)President & Executive Director Comp: $883kMs. Xiaojuan Li (Age 48)Chief Financial Officer Mr. Yijian Wu (Age 54)Secretary to the Board, Company Secretary & Authorised Representative Key CompetitorsAlfresaOTC:ARHCFArjo AB (publ)OTCMKTS:ARRJFEBOS GroupOTCMKTS:EBOSFGalenicaOTCMKTS:GALNFMcKesson EuropeOTCMKTS:CAKFYView All Competitors SHTDY Stock Analysis - Frequently Asked Questions How have SHTDY shares performed in 2024? Sinopharm Group's stock was trading at $13.05 at the beginning of the year. Since then, SHTDY stock has increased by 2.0% and is now trading at $13.3105. View the best growth stocks for 2024 here. Are investors shorting Sinopharm Group? Sinopharm Group saw a increase in short interest in June. As of June 15th, there was short interest totaling 1,900 shares, an increase of 46.2% from the May 31st total of 1,300 shares. Based on an average daily trading volume, of 15,500 shares, the days-to-cover ratio is currently 0.1 days. View Sinopharm Group's Short Interest. How often does Sinopharm Group pay dividends? What is the dividend yield for Sinopharm Group? Sinopharm Group declared a dividend on Saturday, June 15th. Shareholders of record on Wednesday, June 19th will be given a dividend of $0.491 per share on Wednesday, August 28th. This represents a yield of 3.57%. The ex-dividend date of this dividend is Tuesday, June 18th. This is a boost from the stock's previous dividend of $0.49. Read our dividend analysis for SHTDY. How do I buy shares of Sinopharm Group? Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SHTDY) was last updated on 7/5/2024 by MarketBeat.com Staff From Our PartnersObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredThe End of Privacy for Americans… Get Out of Cash Now!Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold.Golden Crest | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinopharm Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.